Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
1(7%)
Results Posted
33%(3 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
3
21%
Ph not_applicable
3
21%
Ph phase_2
3
21%
Ph phase_3
4
29%

Phase Distribution

3

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
3(23.1%)
Phase 2Efficacy & side effects
3(23.1%)
Phase 3Large-scale testing
4(30.8%)
N/ANon-phased studies
3(23.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(9)
Terminated(1)
Other(3)

Detailed Status

Completed9
unknown3
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
90.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (23.1%)
Phase 23 (23.1%)
Phase 34 (30.8%)
N/A3 (23.1%)

Trials by Status

terminated17%
active_not_recruiting17%
unknown321%
completed964%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DRUG
Total Trials
14